Results 81 to 90 of about 2,048,259 (212)
Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes
Haematologica, 2013 The reproducibility of the World Health Organization 2008 classification for myelodysplastic syndromes is uncertain and its assessment was the major aim of this study.
Leonor Senent +5 more
doaj +1 more source
Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms
Cancer Science, Volume 117, Issue 10, Page 2609-2618, October 2026.Splicing factor (SF)‐mutant CH is characterized by relatively late emergence and accelerated clonal expansion in older individuals. This review summarizes its clonal dynamics, disease‐associated consequences of SF mutations in myeloid neoplasms, and candidate mechanisms that may contribute to age‐dependent selection.
Yang Lyu, Yutong Zhang, Ayana Kon
wiley +1 more source
, 2011 Messenger RNA splicing mutations are frequent in myelodysplastic syndromes with ring sideroblasts and predict better prognosis and survival.
Ashkan Emadi
core +1 more source
European Journal of Haematology, Volume 117, Issue 4, Page 1007-1015, October 2026.ABSTRACT Background Real‐world data on transfusion needs of patients with myelodysplastic syndromes (MDS), and the impacts of disease‐modifying therapies (DMTs) are sparse. In 2011, 5‐azacitidine became the first funded DMT for MDS and chronic myelomonocytic leukaemia (CMML) patients in Australia and national patient blood management (PBM) guidelines ...
Allison Mo +5 more
wiley +1 more source
Refractory anemia with ringed sideroblasts (RARS) [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011 Review on Refractory anemia with ringed sideroblasts (RARS), with data on clinics, and the genes involved.
A Cuneo, GL Castoldi
openaire +1 more source
Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk‐Stratification and Management
American Journal of Hematology, Volume 101, Issue 9, Page 2393-2411, September 2026.ABSTRACT Disease Overview The myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increased risk of transformation to acute myelogenous leukemia (AML). MDS occurs more frequently in older males and in individuals with prior exposure to cytotoxic therapy.
Guillermo Garcia‐Manero
wiley +1 more source
, 2020 Refractory anaemia with ring sideroblasts and marked thrombocytosis (RARS-T) is a provisional entity in the World Health Organization (WHO) classification.
Javier Sanchez +7 more
core
Blood, 2020 Introduction: Patients with myelodysplastic syndromes (MDS) experience severe anemia, which is commonly managed with frequent red blood cell transfusions (RBCT) in patients refractory to erythropoiesis-stimulating agents.
E. Oliva +16 more
semanticscholar +1 more source
EfficientNet‐B0–Based Screening of WBC‐Diff Scattergram Images for Hematological Abnormalities
Cancer Medicine, Volume 15, Issue 9, September 2026.ABSTRACT White blood cell differential (WBC‐Diff) scattergrams are used to screen for hematological abnormalities in potential hematopoietic malignancies and abnormal conditions. However, these potential indications can be easily missed. We applied deep learning models to develop a new and rapid workflow by learning the characteristics of WBC‐Diff ...
Mingzhu Long +4 more
wiley +1 more source